Phase II and Pharmacologic Study of Weekly Oral Paclitaxel Plus Cyclosporine in Patients With Advanced Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II and Pharmacologic Study of Weekly Oral Paclitaxel Plus Cyclosporine in Patients With Advanced Non–Small-Cell Lung Cancer

58

Citations

30

References

2002

Year

C.M.F. Kruijtzer, Jan H.M. Schellens, J. Mezger, M. E. Scheulen, Ulrich Keilholz, Jos H. Beijnen, Hilde Rosing, Ron A. A. Mathôt, S. Marcus, Harm van Tinteren,

Journal of Clinical Oncology

Abstract

Oral paclitaxel plus CsA is active and safe in advanced NSCLC, including in patients previously treated with chemotherapy.

References

	Year	Citations

Page 1